No difference in penetrance between truncating and missense/aberrant splicing pathogenic variants in mlh1 and msh2: A prospective lynch syndrome database study | ||
| dc.conicet.organizacion | St Mark’s Hospital | |
| dc.conicet.organizacion | The Norwegian Radium Hospital | |
| dc.conicet.organizacion | European Hereditary Tumour Group | |
| dc.conicet.organizacion | St Mark’s Hospital | |
| dc.conicet.organizacion | The Royal Melbourne Hospital | |
| dc.conicet.organizacion | European Hereditary Tumour Group | |
| dc.conicet.organizacion | Cardiff University | |
| dc.conicet.organizacion | European Hereditary Tumour Group | |
| dc.conicet.organizacion | Universitat Leipzig | |
| dc.conicet.organizacion | Universitat Bonn | |
| dc.conicet.organizacion | University of Melbourne | |
| dc.conicet.organizacion | Aalborg University | |
| dc.conicet.organizacion | Aalborg University | |
| dc.conicet.organizacion | European Hereditary Tumour Group | |
| dc.conicet.organizacion | St Mark’s Hospital | |
| dc.conicet.organizacion | Institut Català d’Oncologia | |
| dc.conicet.organizacion | Universidad de Barcelona | |
| dc.conicet.organizacion | European Hereditary Tumour Group | |
| dc.conicet.organizacion | The Royal Melbourne Hospital | |
| dc.conicet.organizacion | University of Melbourne | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | University of Manchester | |
| dc.conicet.organizacion | Universidad de Newcastle | |
| dc.conicet.organizacion | The Royal Melbourne Hospital | |
| dc.conicet.organizacion | St Mark’s Hospital | |
| dc.conicet.organizacion | University of Vermont | |
| dc.conicet.organizacion | Isala Clinics | |
| dc.conicet.organizacion | University of Groningen | |
| dc.conicet.organizacion | St Mark’s Hospital | |
| dc.conicet.organizacion | European Hereditary Tumour Group | |
| dc.conicet.organizacion | Leids Universitair Medisch Centrum | |
| dc.conicet.organizacion | Fondazione IRCCS Istituto Nazionale dei Tumori | |
| dc.conicet.organizacion | Fondazione IRCCS Istituto Nazionale dei Tumori | |
| dc.conicet.organizacion | Università dell’Insubria | |
| dc.conicet.organizacion | Vita-Salute San Raffaele University | |
| dc.conicet.organizacion | Karolinska Huddinge Hospital | |
| dc.conicet.organizacion | Hospital Fuerzas Armadas | |
| dc.conicet.organizacion | Clínica Universidad de los Andes | |
| dc.conicet.organizacion | Clínica Universidad de los Andes | |
| dc.conicet.organizacion | Universitat Tel Aviv | |
| dc.conicet.organizacion | Sheba Medical Center | |
| dc.conicet.organizacion | University Hospital Basel | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Medicina Traslacional e Ingeniería Biomédica - Hospital Italiano. Instituto de Medicina Traslacional e Ingeniería Biomédica.- Instituto Universitario Hospital Italiano de Buenos Aires. Instituto de Medicina Traslacional e Ingeniería Biomédica | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Medicina Traslacional e Ingeniería Biomédica - Hospital Italiano. Instituto de Medicina Traslacional e Ingeniería Biomédica.- Instituto Universitario Hospital Italiano de Buenos Aires. Instituto de Medicina Traslacional e Ingeniería Biomédica | |
| dc.contributor.author | Dominguez Valentin, Mev | |
| dc.contributor.author | Plazzer, John Paul | |
| dc.contributor.author | Sampson, Julian R. | |
| dc.contributor.author | Engel, Christoph | |
| dc.contributor.author | Aretz, Stefan | |
| dc.contributor.author | Jenkins, Mark A. | |
| dc.contributor.author | Sunde, Lone | |
| dc.contributor.author | Bernstein, Inge | |
| dc.contributor.author | Capella, Gabriel | |
| dc.contributor.author | Balaguer Prunés, Francesc | |
| dc.contributor.author | Macrae, Finlay | |
| dc.contributor.author | Winship, Ingrid M. | |
| dc.contributor.author | Thomas, Huw | |
| dc.contributor.author | Evans, Dafydd Gareth | |
| dc.contributor.author | Burn, John | |
| dc.contributor.author | Greenblatt, Marc | |
| dc.contributor.author | de Vos tot Nederveen Cappel, Wouter H. | |
| dc.contributor.author | Sijmons, Rolf H. | |
| dc.contributor.author | Nielsen, Maartje | |
| dc.contributor.author | Bertario, Lucio | |
| dc.contributor.author | Bonanni, Bernardo | |
| dc.contributor.author | Tibiletti, Maria Grazia | |
| dc.contributor.author | Cavestro, Giulia Martina | |
| dc.contributor.author | Lindblom, Annika | |
| dc.contributor.author | Della Valle, Adriana | |
| dc.contributor.author | Lopez Kostner, Francisco | |
| dc.contributor.author | Alvarez, Karin | |
| dc.contributor.author | Gluck, Nathan | |
| dc.contributor.author | Katz, Lior | |
| dc.contributor.author | Heinimann, Karl | |
| dc.contributor.author | Piñero, Tamara Alejandra | |
| dc.contributor.author | Pavicic, Walter Hernan | |
| dc.date.issued | 2021-06 | |
| dc.description.abstract | Background. Lynch syndrome is the most common genetic predisposition for hereditary cancer. Carriers of pathogenic changes in mismatch repair (MMR) genes have an increased risk of developing colorectal (CRC), endometrial, ovarian, urinary tract, prostate, and other cancers, depending on which gene is malfunctioning. In Lynch syndrome, differences in cancer incidence (penetrance) according to the gene involved have led to the stratification of cancer surveillance. By contrast, any differences in penetrance determined by the type of pathogenic variant remain unknown. Objective. To determine cumulative incidences of cancer in carriers of truncating and missense or aberrant splicing pathogenic variants of the MLH1 and MSH2 genes. Methods. Carriers of pathogenic variants of MLH1 (path_MLH1) and MSH2 (path_MSH2) genes filed in the Prospective Lynch Syndrome Database (PLSD) were categorized as truncating or missense/aberrant splicing according to the InSiGHT criteria for pathogenicity. Results. Among 5199 carriers, 1045 had missense or aberrant splicing variants, and 3930 had truncating variants. Prospective observation years for the two groups were 8205 and 34,141 years, respectively, after which there were no significant differences in incidences for cancer overall or for colorectal cancer or endometrial cancers separately. Conclusion. Truncating and missense or aberrant splicing pathogenic variants were associated with similar average cumulative incidences of cancer in carriers of path MLH1 and path_MSH2. | es |
| dc.description.fil | Fil: Dominguez Valentin, Mev. St Mark’s Hospital; Reino Unido. The Norwegian Radium Hospital; Noruega. European Hereditary Tumour Group; Reino Unido | |
| dc.description.fil | Fil: Plazzer, John Paul. St Mark’s Hospital; Reino Unido. The Royal Melbourne Hospital; Australia | |
| dc.description.fil | Fil: Sampson, Julian R.. European Hereditary Tumour Group; Reino Unido. Cardiff University; Reino Unido | |
| dc.description.fil | Fil: Engel, Christoph. European Hereditary Tumour Group; Reino Unido. Universitat Leipzig; Alemania | |
| dc.description.fil | Fil: Aretz, Stefan. Universitat Bonn; Alemania | |
| dc.description.fil | Fil: Jenkins, Mark A.. University of Melbourne; Australia | |
| dc.description.fil | Fil: Sunde, Lone. Aalborg University; Dinamarca | |
| dc.description.fil | Fil: Bernstein, Inge. Aalborg University; Dinamarca | |
| dc.description.fil | Fil: Capella, Gabriel. European Hereditary Tumour Group; Reino Unido. St Mark’s Hospital; Reino Unido. Institut Català d’Oncologia; España | |
| dc.description.fil | Fil: Balaguer Prunés, Francesc. Universidad de Barcelona; España | |
| dc.description.fil | Fil: Macrae, Finlay. European Hereditary Tumour Group; Reino Unido. The Royal Melbourne Hospital; Australia | |
| dc.description.fil | Fil: Winship, Ingrid M.. University of Melbourne; Australia | |
| dc.description.fil | Fil: Thomas, Huw. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Evans, Dafydd Gareth. University of Manchester; Reino Unido | |
| dc.description.fil | Fil: Burn, John. Universidad de Newcastle; Australia. The Royal Melbourne Hospital; Australia. St Mark’s Hospital; Reino Unido | |
| dc.description.fil | Fil: Greenblatt, Marc. University of Vermont; Estados Unidos | |
| dc.description.fil | Fil: de Vos tot Nederveen Cappel, Wouter H.. Isala Clinics; Países Bajos | |
| dc.description.fil | Fil: Sijmons, Rolf H.. University of Groningen; Países Bajos. St Mark’s Hospital; Reino Unido. European Hereditary Tumour Group; Reino Unido | |
| dc.description.fil | Fil: Nielsen, Maartje. Leids Universitair Medisch Centrum; Países Bajos | |
| dc.description.fil | Fil: Bertario, Lucio. Fondazione IRCCS Istituto Nazionale dei Tumori; Italia | |
| dc.description.fil | Fil: Bonanni, Bernardo. Fondazione IRCCS Istituto Nazionale dei Tumori; Italia | |
| dc.description.fil | Fil: Tibiletti, Maria Grazia. Università dell’Insubria; Italia | |
| dc.description.fil | Fil: Cavestro, Giulia Martina. Vita-Salute San Raffaele University; Italia | |
| dc.description.fil | Fil: Lindblom, Annika. Karolinska Huddinge Hospital; Suecia | |
| dc.description.fil | Fil: Della Valle, Adriana. Hospital Fuerzas Armadas; Uruguay | |
| dc.description.fil | Fil: Lopez Kostner, Francisco. Clínica Universidad de los Andes; Chile | |
| dc.description.fil | Fil: Alvarez, Karin. Clínica Universidad de los Andes; Chile | |
| dc.description.fil | Fil: Gluck, Nathan. Universitat Tel Aviv; Israel | |
| dc.description.fil | Fil: Katz, Lior. Sheba Medical Center; Israel | |
| dc.description.fil | Fil: Heinimann, Karl. University Hospital Basel; Suiza | |
| dc.description.fil | Fil: Piñero, Tamara Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Medicina Traslacional e Ingeniería Biomédica - Hospital Italiano. Instituto de Medicina Traslacional e Ingeniería Biomédica.- Instituto Universitario Hospital Italiano de Buenos Aires. Instituto de Medicina Traslacional e Ingeniería Biomédica; Argentina | |
| dc.description.fil | Fil: Pavicic, Walter Hernan. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Medicina Traslacional e Ingeniería Biomédica - Hospital Italiano. Instituto de Medicina Traslacional e Ingeniería Biomédica.- Instituto Universitario Hospital Italiano de Buenos Aires. Instituto de Medicina Traslacional e Ingeniería Biomédica; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Dominguez Valentin, Mev; Plazzer, John Paul; Sampson, Julian R.; Engel, Christoph; Aretz, Stefan; et al.; No difference in penetrance between truncating and missense/aberrant splicing pathogenic variants in mlh1 and msh2: A prospective lynch syndrome database study; Multidisciplinary Digital Publishing Institute; Journal of Clinical Medicine; 10; 13; 6-2021; 1-12 | es |
| dc.identifier.eissn | 2077-0383 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/211951 | |
| dc.journal.ciudad | Basilea | es |
| dc.journal.number | 13 | es |
| dc.journal.pagination | 1-12 | es |
| dc.journal.pais | Suiza | es |
| dc.journal.title | Journal of Clinical Medicine | es |
| dc.journal.volume | 10 | es |
| dc.language.iso | eng | es |
| dc.publisher | Multidisciplinary Digital Publishing Institute | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2077-0383/10/13/2856 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.3390/jcm10132856 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | ABERRANT SPLICING | es |
| dc.subject | CANCER INCIDENCE | es |
| dc.subject | LYNCH SYNDROME | es |
| dc.subject | MISSENSE | es |
| dc.subject | MLH1 | es |
| dc.subject | MSH2 | es |
| dc.subject | PENETRANCE | es |
| dc.subject | TRUNCATING | es |
| dc.subject.classification | Oncología | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | No difference in penetrance between truncating and missense/aberrant splicing pathogenic variants in mlh1 and msh2: A prospective lynch syndrome database study | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.e690d8ed-0aa8-496d-aed7-d617dcf31d03_B.pdf
- Tamaño:
- 1.11 MB
- Formato:
- Adobe Portable Document Format